1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United StatesALIMENTARY PHARMACOLOGY & THERAPEUTICS
2024Safety and Efficacy of Ticagrelor Monotherapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized TrialsCIRCULATION
2024CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial INVESTIGATIONAL NEW DRUGS
2024Prediction of In-Hospital Mortality for Ischemic Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation JOURNAL OF THE AMERICAN HEART ASSOCIATION
2024Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer CLINICAL CANCER RESEARCH
2024Kidney Transplantation From Brain-Dead Donors With Hepatitis B or C in South Korea: A 2015 to 2020 Korean Organ Transplantation Registry Data AnalysisTRANSPLANTATION PROCEEDINGS
2024Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
2024A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2024Reply to: Comments on “Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients”INTERNATIONAL JOURNAL OF CANCER
2024Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' replyLANCET ONCOLOGY
2024Atrial fibrillation: comorbidities, lifestyle, and patient factors LANCET REGIONAL HEALTH-EUROPE
2024Synthetic Data Improve Survival Status Prediction Models in Early-Onset Colorectal CancerJCO CLINICAL CANCER INFORMATICS
2024Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722 JOURNAL OF CLINICAL ONCOLOGY
2024Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular UltrasoundJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2024The KAAACI Guidelines for Sublingual Immunotherapy ALLERGY ASTHMA & IMMUNOLOGY RESEARCH
2024Prognostic Implication of Platelet Reactivity According to Left Ventricular Systolic Dysfunction Status in Patients Treated With Drug-Eluting Stent Implantation: Analysis of the PTRG-DES Consortium JOURNAL OF KOREAN MEDICAL SCIENCE
2024The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma GUT AND LIVER
2024Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational StudyANTICANCER RESEARCH
2024Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection JHEP REPORTS
2024Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study CLINICAL CANCER RESEARCH

Recent Submissions

Browse

Links